MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of ...
Medical technology company Inspire Medical Systems (NYSE:INSP) in Q2 CY2025, with sales up 10.8% year on year to $217.1 million. On the other hand, the company’s full-year revenue guidance of $905 ...
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with ...
I assign a HOLD rating to INSP due to execution risk from Inspire V rollout delays, IT integration, and reimbursement timing. Management's lowered guidance and a questionable share buyback program ...
Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per ...
Inspire Medical Systems, Inc. (NYSE:INSP) stock is plunging after the company released its second-quarter earnings and cut its annual guidance. Track INSP s tock’s live prices here. The company, which ...
StockStory.org on MSN
Inspire Medical Systems (INSP): Buy, sell, or hold post Q4 earnings?
Shareholders of Inspire Medical Systems would probably like to forget the past six months even happened. The stock dropped 22 ...
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of ...
Defendants touted Inspire V as groundbreaking, with the potential to drive revenue growth in an increasingly competitive market. However, the complaint continues, the Inspire V launch was a disaster ...
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading ...
Revenue for the second quarter is anticipated to be $195.9 million, a 30% increase over the same quarter of 2023 U.S. revenue is expected to be $187.8 million, a 30% increase over the same quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results